Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antitumor compounds from Ajinomoto

May 6, 1998

GenVec in-licenses rights to TNF-alpha for gene therapy applications

May 5, 1998

Phase I trial results presented for the antifolate LY-231514

May 5, 1998

Natural antitumor substances with broad-spectrum activity isolated by Banyu scientists

May 5, 1998

Antitumor agents of microbial origin discovered by Nippon Kayaku

May 5, 1998

Zeneca seeks new labeling for breast cancer therapy

May 5, 1998

FDA grants accelerated approval for Xeloda

May 4, 1998

Targeted cytotoxic therapy cures breast cancer in mice at nontoxic doses

May 1, 1998

Cancer drug discovery alliance formed

April 30, 1998

KW-2170: in vitro and in vivo antitumor activity of a new pyrazoloacridone

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...